Hy-Gro Chemicals Pharmtek Profile
Key Indicators
- Authorised Capital ₹ 20.00 Cr
- Paid Up Capital ₹ 12.00 Cr
- Company Age 67 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 48.23 Cr
- Satisfied Charges ₹ 2.68 Cr
- Revenue Growth 40.77%
- Profit Growth 120.97%
- Ebitda 719.75%
- Net Worth 1.59%
- Total Assets 3.34%
About Hy-Gro Chemicals Pharmtek
Hy-Gro Chemicals Pharmtek Private Limited (HCPPL) was founded in India on 31 May 1957 and has a glorious history of 67 years and eight months. Its registered office is in Medak, Telangana, India.
The Corporate was formerly known as Hy-Gro Chemicals P Ltd. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 20.00 Cr and a paid-up capital of Rs 12.00 Cr.
The company currently has active open charges totaling ₹48.23 Cr. The company has closed loans amounting to ₹2.68 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Hy-Gro Chemicals Pharmtek Private Limited India is Rashi Mirani as COMPANY SECRETARY. Deevi Iyengar, Anuradha Bishnoi, and Vivek Bishnoi serve as directors at the Company.
Company Details
- Location
Medak, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24110TG1957PTC028631
- Company No.
028631
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 May 1957
- Date of AGM
26 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
What products or services does Hy-Gro Chemicals Pharmtek Private Limited offer?
Hy-Gro Chemicals Pharmtek Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Antipyretic and Analgesic API, Common Disease Medicines, Pharmaceutical Medicine, Food Preservative, Propionic Acid.
Who are the key members and board of directors at Hy-Gro Chemicals Pharmtek?
Executive Team (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Vivek Bishnoi ![]() | Managing Director | 27-Jun-2011 | Current |
Rashi Mirani | Company Secretary | 15-Jul-2020 | Current |
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Deevi Iyengar ![]() | Director | 18-Nov-2004 | Current |
Anuradha Bishnoi ![]() | Director | 21-May-1973 | Current |
Financial Performance of Hy-Gro Chemicals Pharmtek.
Hy-Gro Chemicals Pharmtek Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 40.77% increase. The company also saw a substantial improvement in profitability, with a 120.97% increase in profit. The company's net worth moved up by a moderate rise of 1.59%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Hy-Gro Chemicals Pharmtek?
In 2023, Hy-Gro Chemicals Pharmtek had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹48.23 Cr
₹2.68 Cr
Charges Breakdown by Lending Institutions
- Indian Overseas Bank : 48.23 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
24 May 1996 | Indian Overseas Bank | ₹48.23 Cr | Open |
14 Oct 2010 | Indian Overseas Bank | ₹2.68 Cr | Satisfied |
How Many Employees Work at Hy-Gro Chemicals Pharmtek?
Unlock and access historical data on people associated with Hy-Gro Chemicals Pharmtek, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Hy-Gro Chemicals Pharmtek, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hy-Gro Chemicals Pharmtek's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.